APOTHEEK BRABANTDAM
ActiveSummary
APOTHEEK BRABANTDAM has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €49k and a net result of €2k. Equity is growing by ~8.1% per year across the filed fiscal years. Its solvency ranks better than 66% of 18280 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability72▲+72
Solvency77▲+1
Growth52=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity ample (current ratio 2.0 against 2.02 in 2024; short-term debt: 47.5% and cash: 66.4% of total assets), and 47.5% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
52.5%
Return on assets
2.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-03-2026, 140 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
140 d early
2024
125 d early
2023
1 d late
2022
31 d late
2021
30 d late
2020
31 d late
2019
101 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€49k▲ 4.8%
2024 · €47k
2018: €23k
2019: €38k
2020: €53k
2021: €44k
2022: €66k
2023: €72k
2024: €47k
2018 → 2025
Total assets
€93k▲ 1.5%
2024 · €92k
2018: €247k
2019: €279k
2020: €258k
2021: €267k
2022: €282k
2023: €151k
2024: €92k
2018 → 2025
Net result
€2k
2024 · €-26k
2018: €13k
2019: €15k
2020: €15k
2021: €-9k
2022: €22k
2023: €31k
2024: €-26k
2018 → 2025
Working capital
€44k▲ 6.6%
2024 · €42k
2018: €47k
2019: €97k
2020: €96k
2021: €86k
2022: €110k
2023: €67k
2024: €42k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€44k-€66k▲ 51.2%€72k▲ 9.1%€47k▼ 35.5%€49k▲ 4.8%
Operating result€-5k-€31k€36k▲ 16.4%€-25k€3k
Net result€-9k-€22k€31k▲ 38.0%€-26k€2k
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €3k after a loss of €25k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €93k
Fixed assets
€5k ▼ 52.2%
Current assets
€89k ▲ 7.7%
Equity and liabilities €93k
Equity
€49k ▲ 4.8%
Debt
€44k ▼ 2.0%
Debt's share of the balance-sheet total falls from 49.2% to 47.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€8k▲
2024 · €-20k
Cash flow
€7k▲
2024 · €-21k
Current ratio
2.00▼
2024 · 2.02
Debt to equity
0.90▼
2024 · 0.97
ROE
4.6%▲
2024 · -55.1%
ROA
2.4%▲
2024 · -28.0%
Interest coverage
22.00▲
2024 · -41.66
Debt ≤ 1 year
€44k▲
2024 · €41k
Debt > 1 year
€0▼
2024 · €4k
Income taxes
€0▼
2024 · €112
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet
Code20242025
Assets
Total assets20/58€92k€93k▲
Fixed assets21/28€10k€5k▼
Tangible fixed assets22/27€10k€5k▼
Furniture and vehicles24€10k€5k▼
Current assets29/58€82k€89k▲
Amounts receivable within one year40/41€8k€26k▲
Trade receivables40€5k€26k▲
Other amounts receivable41€3k€0▼
Cash at bank and in hand54/58€73k€62k▼
Deferred charges and accrued income490/1€1k€1k▲
Equity and liabilities
Total equity and liabilities10/49€92k€93k▲
Equity10/15€47k€49k▲
Contributions10/11€9k€9k=
Reserves13€37k€40k▲
Distributable reserves133€37k€40k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€45k€44k▼
Amounts payable after more than one year17€4k€0▼
Financial debts170/4€4k€0▼
Amounts payable within one year42/48€41k€44k▲
Current portion of amounts payable after more than one year42€5k€4k▼
Trade debts44€140€9▼
Suppliers440/4€140€9▼
Taxes, remuneration and social security45€728€4k▲
Taxes450/3€728€4k▲
Remuneration and social security454/9€0-
Other amounts payable47/48€35k€35k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€5k=
Other operating charges640/8€399€427▲
Gross operating margin9900€-20k€8k▲
Operating profit (loss)9901€-25k€3k▲
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€484€343▼
Recurring financial charges65€484€343▼
Profit (loss) for the period before taxes9903€-26k€2k▲
Income taxes67/77€112€0▼
Profit (loss) for the period9904€-26k€2k▲
Profit (loss) for the period to be appropriated9905€-26k€2k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-26k€2k▲
Profit (loss) brought forward from the previous period14P€0-
Transfer from equity791/2€26k€0▼
Transfer to equity691/2€0€2k▲
To other reserves6921€0€2k▲
Profit to be distributed694/7€0-
Directors or managers695€0-
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Back to profitnet €2k
Net result €2k after one loss-making year.
28-03
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €-26k ▼183%
Net result drops to €-26k, the lowest in the series; recovery starts the following year.
01-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 1 day late
2023
31-12
Financial
Highest result since 2018net €31k ▲38%
Operating result €36k, net result €31k, both a record.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
2022
31-12
Financial
Back to profitnet €22k
Net result €22k after one loss-making year.
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 30 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
09-11
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 101 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Brabantdam 739000 GentGround area
62 m²
Building footprint
62 m²
Volume, LiDAR
987 m³
Parcel 44804D1838/00E000, Flanders · tallest building 18.9 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK BRABANTDAM
since 20172.262.608.835
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44804D1838/00E000 | Flanders | 62 m² | 1 · 62 m² | 18.9 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2023 · 2 entries · 4,000 EUR awarded · 4,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 2,000 EUR | 2,000 EUR |
| 2022 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Similar companies · same sector, comparable size
BILOBA HEVERLEE
BE 0455.548.721
Leuven · Eq €48,973
PHARMACIE DUCHENE-COLINET
BE 0431.115.906
Dalhem · Eq €48,732
Pharmacie Nathalie Elsen
BE 0770.286.601
Andenne · Eq €49,116
BEAUTY PHARMA
BE 0729.575.206
Schaarbeek · Eq €49,296
APOTHEEK LORMANS-NELISSEN
BE 0466.881.586
Hasselt · Eq €48,485
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,738 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-02-2017
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
55100Hotels and similar accommodation
82990Other business support services
96999Other personal services
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:apotheek@brabantdam.be
Phone:092254410